Results 211 to 220 of about 326,770 (247)

AAV Vectors: Are They Safe?

Human Gene Therapy, 2020
openaire   +2 more sources

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

Molecular Therapy, 2020
Helena Costa-Verdera, Federico Mingozzi, Klaudia Kuranda   +2 more
exaly  

An AAV vector for glial cells

Nature Biotechnology
Irvin T. Garza, Steven J. Gray
openaire   +2 more sources

Design of AAV Vectors for Delivery of Large or Multiple Transgenes

Methods in Molecular Biology, 2019
Yi Lai, Dongsheng Duan, Junling Zhao
exaly  

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions

Frontiers in Immunology, 2014
Etiena Basner-Tschakarjan
exaly  

EFFICIENT AAV VECTORS

1999
DONG JIAN-YUN, KAN YUET WAI
openaire   +2 more sources

AAV VECTORS TARGETED TO OLIGODENDROCYTES

2014
MCCOWN THOMAS, GRAY STEVEN
openaire   +6 more sources

ENGINEERED AAV VECTORS

2022
MICHALAKIS STYLIANOS, ZOBEL LENA, BABUTZKA SABRINA, BIEL MARTIN, AMMER HERMANN   +4 more
openaire   +1 more source

Analysis of Tumors Arising in Male B6C3F1 Mice With and Without AAV Vector Delivery to Liver

Molecular Therapy, 2006
Peter Bell, James Wilson
exaly  

Metabolic Biotinylation Provides a Unique Platform for the Purification and Targeting of Multiple AAV Vector Serotypes

Molecular Therapy, 2006
Matthew D Stachler, Jeffrey S Bartlett
exaly